Research and Development
Biosimilars could save healthcare systems $100bn by 2020
March 30, 2016 Research and Development, Sales and Marketing biosimilars
GSK’s Nucala gets regulatory approval in Japan to treat bronchial asthma
March 29, 2016 Manufacturing and Production, Research and Development GlaxoSmithKline, Japan, Nucala, US FDA, bronchial asthma
Valeant’s outgoing CEO subpoenaed by US congressional committee
March 29, 2016 Medical Communications, Research and Development Drug pricing, Michael Pearson, US, Valeant, committee, pearson, pharma, price hikes, senate aging committee, subpoena, subpoenaed
TREND: Rare disease, cancer drugs will drive pharma M&A’s, growth
March 29, 2016 Manufacturing and Production, Research and Development, Sales and Marketing M&A, MA, Orphan Drugs, cancer drugs
Novo Nordisk breaks ground on new $2 billion production facility in North Carolina
March 29, 2016 Manufacturing and Production, Research and Development $2 billion, Clayton, Novo, Novo Nordisk, building, diabetes, nordisk, north carolina, production facility
US FDA issues observations for Natco Pharma’s Indian plants
March 29, 2016 Manufacturing and Production, Research and Development, Sales and Marketing
Portola Pharma stock drops on dismal Phase III trial results for blood-clot drug
March 29, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Portola Pharmaceuticals, blood clot drug, drug trial, phase III
FDA issues CRL for Takeda/Lundbeck’s Brintellix
March 29, 2016 Manufacturing and Production, Research and Development Lundbeck, Takeda, brintellix
Phase III trial initiated for enzalutamide in treatment of prostate cancer
March 24, 2016 Research and Development Astellas, Medivation, arches, clinical trial, enzalutamide, phase 3, phase III, prostate cancer
MSD teams up with Harvard to develop new leukaemia treatments
March 24, 2016 Medical Communications, Research and Development AML, Harvard, MSD, leukaemia
EMA to review Pfizer’s Xeljanz for patients with rheumatoid arthritis
March 24, 2016 Research and Development, Sales and Marketing EMA, Pfizer, Xeljanz, approval, authorisation, marketing, review, rheumatoid arthritis
Teva announces FDA approval for asthma injection, Cinqair
March 24, 2016 Research and Development, Sales and Marketing FDA, Teva, approval, asthma, cinqair
Biotech Micreos appoints CMO to lead clinical development of antibiotic alternative
March 23, 2016 Research and Development
Sanofi and Regeneron meet endpoint in Phase III Praluent study
March 23, 2016 Research and Development Regeneron, Sanofi, endpoint, escape, hefh, odyssey, phase 3, phase III, positive, praulent, trial
Bristol-Myers Squibb to acquire Padlock Therapeutics for up to $600m
March 23, 2016 Research and Development, Sales and Marketing Bristol-Myers Squibb, Padlock Therapeutics, rheumatoid arthritis
